259
Participants
Start Date
October 31, 2005
Primary Completion Date
June 30, 2010
Study Completion Date
June 30, 2010
Vaccine+HBIG
Recombinant hepatitis B vaccine at birth, 6 weeks, 10 weeks, and 14 weeks in the dose of 10 mcg (0.5 mL), by intramuscular injection in the anterolateral thigh; PLUS HBIG in the dose of 0.5 mL intramuscularly immediately after birth
Vaccine+Placebo
Recombinant hepatitis B vaccine at birth, 6 weeks, 10 weeks, and 14 weeks in the dose of 10 mcg (0.5 mL), by intramuscular injection in the anterolateral thigh; PLUS placebo intramuscularly immediately after birth
Lady Hardinge Medical College, New Delhi
Indian Council of Medical Research
OTHER_GOV
Lady Hardinge Medical College
OTHER_GOV
Govind Ballabh Pant Hospital
OTHER_GOV